Gilead Sciences’s Leap Therapeutics LPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.58M Hold
5,319,148
0.12% 10
2025
Q1
$1.62M Hold
5,319,148
0.14% 12
2024
Q4
$15.3M Buy
+5,319,148
New +$15.3M 0.99% 7